CVS · Categories · Downgrades
CVS - Analyst downgrades
CVS Health Corporation (CVS) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for CVS
- CVS Health downgraded by TD Cowen with a new price targetTD Cowen downgraded CVS Health from Buy to Hold and set a new price target of $59.00 from $99.00 previously
- CVS Health downgraded by UBS with a new price targetUBS downgraded CVS Health from Buy to Neutral and set a new price target of $60.00 from $85.00 previously
- CVS Health downgraded by Cantor FitzgeraldCantor Fitzgerald downgraded CVS Health from Overweight to Neutral
- CVS Health downgraded by Leerink Partners with a new price targetLeerink Partners downgraded CVS Health from Outperform to Market Perform and set a new price target of $60.00 from $87.00 previously
- CVS Health downgraded by Edward JonesEdward Jones downgraded CVS Health from Buy to Hold
- CVS Health downgraded by Evercore ISI with a new price targetEvercore ISI downgraded CVS Health from Outperform to In-line and set a new price target of $100.00 from $120.00 previously
- CVS Health downgraded by Bernstein with a new price targetBernstein downgraded CVS Health from Outperform to Mkt Perform and set a new price target of $112.00 from $122.00 previously
- CVS Health downgraded by Deutsche Bank with a new price targetDeutsche Bank downgraded CVS Health from Buy to Hold and set a new price target of $110.00
- CVS Health downgraded by Raymond James with a new price targetRaymond James downgraded CVS Health from Strong Buy to Outperform and set a new price target of $120.00 from $115.00 previously
- CVS Health downgraded by Raymond JamesRaymond James downgraded CVS Health from Strong Buy to Outperform
- CVS Health downgraded by GuggenheimGuggenheim downgraded CVS Health from Buy to Neutral